calendar
8 catalysts · 18,987 approval · 6,833 phase readout · 5,000 device 510k · 4,728 grant · 3,499 8k filing · 2,000 device pma
8 catalysts · 18,987 approval · 6,833 phase readout · 5,000 device 510k · 4,728 grant · 3,499 8k filing · 2,000 device pma
Therapy area: Dermatology. Indication: Chronic Urticaria
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
Prescription Drug User Fee Act goal date of July 17, 2026
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
action date of January 4, 2027
action date of Jan. 21, 2027